目录
REVIEW
- Hepatitis C virus: A critical approach to who really needs treatment
- Current aspects of renal dysfunction after liver transplantation
- Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response
- Metabolic and nutritional triggers associated with increased risk of liver complications in SARS-CoV-2
- Recent updates on progressive familial intrahepatic cholestasis types 1, 2 and 3: Outcome and therapeutic strategies
- Is there a role of lipid-lowering therapies in the management of fatty liver disease?
MINIREVIEWS
- Targets of immunotherapy for hepatocellular carcinoma: An update
- Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
- Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence
- Mitochondrial hepatopathy: Anticipated difficulties in management of fatty acid oxidation defects and urea cycle defects
ORIGINAL ARTICLE
- Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil
- Prognostic factors of survival and a new scoring system for liver resection of colorectal liver metastasis
- Short-term outcomes of robotic liver resection: An initial singleinstitution experience
- Assessment for the minimal invasiveness of laparoscopic liver resection by interleukin-6 and thrombospondin-1
- Can the computed tomography texture analysis of colorectal liver metastases predict the response to first-line cytotoxic chemotherapy?
- Correlation of hepatitis B surface antigen expression with clinicopathological and biochemical parameters in liver biopsies: A comprehensive study
- COVID-19 emergency: Changes in quality of life perception in patients with chronic liver disease-An Italian single-centre study
CASE REPORT
LETTER TO THE EDITOR